CRC Research Update — May 24, 2026
Today's colorectal cancer research highlights
The CRC Digest
Curated CRC research — accessible, accurate, actionable
Sunday, May 24, 2026
1 min readIMPORTANT: The CRC Digest curates and summarizes publicly available research for informational and educational purposes only. Nothing in this newsletter constitutes medical advice, diagnosis, or treatment recommendation. The information provided should not be used as a substitute for professional medical advice. Always seek the guidance of your physician or other qualified health provider with any questions regarding a medical condition or treatment. Content is generated with AI assistance and reviewed by the editorial team. We are not medical professionals. Individual results, treatments, and outcomes vary.
CRC Research Update
-
Dual checkpoint blockade shows early survival benefit in MSI-H metastatic CRC
(Clinical Colorectal Cancer)
-
ctDNA monitoring reveals "dilution phenomenon" during metastatic CRC treatment
(Clinical Colorectal Cancer)
-
Deep learning detects colorectal cancer on non-contrast CT scans
A multicenter international cohort study examines colorectal cancer detection using non-contrast CT and deep learning. (Annals of Oncology)
-
Updated survival analysis for bevacizumab in metastatic CRC
(Clinical Colorectal Cancer)
These findings continue to refine our understanding of CRC biology and treatment strategies. As always, discuss any questions about your specific situation with your care team.
The CRC Digest
Research intelligence for the colorectal cancer community
Get CRC research intelligence delivered weekly — free.
SubscribeBrowse by Topic
Not Medical Advice
The CRC Digest provides research summaries for informational and educational purposes only. This is not medical advice. Always consult your healthcare provider before making any decisions about your care.
Content is curated with AI assistance and reviewed by the editorial team.